Nov 03, 2022 / 02:00PM GMT
Operator
Welcome to the Medivir Q3 2022 Report. (Operator Instructions)
I'll now hand you over to the CEO, Jens Lindberg. Please begin.
Jens Lindberg - Medivir AB(publ)-CEO
Thank you, and welcome, everyone, to our Q3 call. You can -- operator, please proceed to Slide #2.
Joined in the room with me is Magnus Christensen, our CFO, who will go through the financial numbers towards the end of the call; and Fredrik Ãberg, our Chief Scientific Officer, who will walk us through some of the elements of the program today.
So with that, I think we can move to Slide 3. Important information. Of course, I'm not going to go through it in detail. You'll find the presentation on our website, so please access it there for further information.
And with that said, we can move to Slide 5, please. So highlights during the last quarter. We're going to divide up the presentation in 2 parts as we usually do. We're going to focus our efforts on our lead asset, fostrox, but also touch a bit on our overall portfolio
Q3 2022 Medivir AB Earnings Call Transcript
Nov 03, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers